U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 146

Tests names and labsConditionsGenes, analytes, and microbesMethods

Colorectal Cancer Panel

QDx Pathology Services, Inc.
United States
619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome

QDx Pathology Services, Inc.
United States
55
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome

Clariti Diagnostics Laboratories LLC
United States
55
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Panel

Clariti Diagnostics Laboratories LLC
United States
619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
3930
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

PREVENTEST

GeneID Lab - Advanced Molecular Diagnostics
United States
6034
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae eMERGE Panel

Invitae
United States
5916
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome via MLPA of PMS2

PreventionGenetics, part of Exact Sciences
United States
31
  • D Deletion/duplication analysis

Common Hereditary Cancer Screening Panel

PreventionGenetics, part of Exact Sciences
United States
9455
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoBreast

Centogene AG - the Rare Disease Company
Germany
5828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11468
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

PMS2 - MLPA

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis

PMS2 - Sanger sequencing

Centogene AG - the Rare Disease Company
Germany
21
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer + RNA Panel

Invitae
United States
14363
  • D Deletion/duplication analysis

Invitae Common Hereditary Cancers + RNA Panel

Invitae
United States
11447
  • D Deletion/duplication analysis

Invitae eMERGE Panel

Invitae
United States
5916
  • D Deletion/duplication analysis

Gastric Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
3619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 146

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.